France
· Delayed Price · Currency is EUR Novacyt Statistics
Total Valuation
Novacyt has a market cap or net worth of EUR 40.84 million. The enterprise value is 17.49 million.
| Market Cap | 40.84M |
| Enterprise Value | 17.49M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Novacyt has 70.54 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 70.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 0.02% |
| Float | 70.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.87 |
| PB Ratio | 0.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.39 |
| EV / Sales | 0.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.50 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.04 |
| Quick Ratio | 3.70 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.45 |
| Interest Coverage | -18.49 |
Financial Efficiency
Return on equity (ROE) is -42.04% and return on invested capital (ROIC) is -33.88%.
| Return on Equity (ROE) | -42.04% |
| Return on Assets (ROA) | -27.98% |
| Return on Capital (ROIC) | -33.88% |
| Revenue Per Employee | 91,224 |
| Profits Per Employee | -184,999 |
| Employee Count | 237 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 10.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.32% in the last 52 weeks. The beta is -1.86, so Novacyt's price volatility has been lower than the market average.
| Beta (5Y) | -1.86 |
| 52-Week Price Change | -2.32% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.68 |
| Relative Strength Index (RSI) | 37.59 |
| Average Volume (20 Days) | 317,159 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novacyt had revenue of EUR 21.89 million and -44.40 million in losses. Loss per share was -0.63.
| Revenue | 21.89M |
| Gross Profit | -12.93M |
| Operating Income | -61.14M |
| Pretax Income | -45.02M |
| Net Income | -44.40M |
| EBITDA | -45.11M |
| EBIT | -61.14M |
| Loss Per Share | -0.63 |
Balance Sheet
The company has 38.86 million in cash and 15.50 million in debt, giving a net cash position of 23.36 million or 0.33 per share.
| Cash & Cash Equivalents | 38.86M |
| Total Debt | 15.50M |
| Net Cash | 23.36M |
| Net Cash Per Share | 0.33 |
| Equity (Book Value) | 83.05M |
| Book Value Per Share | 1.18 |
| Working Capital | 48.81M |
Cash Flow
In the last 12 months, operating cash flow was -33.48 million and capital expenditures -1.32 million, giving a free cash flow of -34.80 million.
| Operating Cash Flow | -33.48M |
| Capital Expenditures | -1.32M |
| Free Cash Flow | -34.80M |
| FCF Per Share | -0.49 |
Margins
Gross margin is -59.05%, with operating and profit margins of -279.25% and -202.80%.
| Gross Margin | -59.05% |
| Operating Margin | -279.25% |
| Pretax Margin | -205.65% |
| Profit Margin | -202.80% |
| EBITDA Margin | -206.05% |
| EBIT Margin | -279.25% |
| FCF Margin | -158.95% |
Dividends & Yields
Novacyt does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novacyt has an Altman Z-Score of -0.03. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.03 |
| Piotroski F-Score | n/a |